# Anakinra for Preterm Infants Pilot

> **NCT05280340** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Monash Medical Centre** · enrollment: 25 (actual)

## Conditions studied

- Prematurity; Extreme
- Inflammation

## Interventions

- **DRUG:** Anakinra

## Key facts

- **NCT ID:** NCT05280340
- **Lead sponsor:** Monash Medical Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-15
- **Primary completion:** 2024-03-21
- **Final completion:** 2025-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05280340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05280340, "Anakinra for Preterm Infants Pilot". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05280340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*